Event Type
Disclosure
Voluntary
Variant
8-K
. Other Events On March 2, 2026, the Company issued a press-release over Globe Newswire, enclosed hereto as Exhibit 99.1, under the title: Bioxytran, Inc. Repor
Financial Statements and Exhibits. Exhibit Number Description 99.1* Press Release dated March 2, 2026, entitled “Bioxytran, Inc. Reports Positive Phase 1b/2a Cl